GENE SEPT5 TKI PREGNANCY PATIENTS IN BRAZIL CHRONIC PHASE SURVIVAL DASATINIBE SARS-COV-2 TYROSINE KINASE INHIBITORS PBSC BCR-ABL1 CARDIOVASCULAR EVENTS BCR-ABL WHO DASATINIB NILOTINIBE D-HPLC CHRONIC MYELOID LEUKAEMIA NILOTINIB BCR-ABL MUTATIONS ALLOGENEIC BONE MARROW CYTOGENETIC REMISSION GENERIC IMATINIB PERIPHERAL BLOOD STEM CELLS TRANSPLANTATION HOCT1 THIRD-LINE TKI TREATMENT ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION BONE MARROW TRANSPLANTATION NON-MYELOABLATIVE IMATINIB CARDIOVASCULAR TFR MULTICENTER STUDY COMORBIDITIES HMGCLL1 BCR/ABL STEM CELL TRANSPLANTATION ENACT FIRST LINE TERAPHY EDI-PIO PEDIATRIC PATIENTS BRAZIL F359V LOW EDUCATION LEVEL 2022 CHRONIC MYELOID LEUKEMIA CARDIOVASCULAR RISK PIOGLITAZONE BCR/ABL GENE DISCONTINUATION TRIAL CHILDREN AND ADOLESCENTS